OREX is a biotech stock that has the smallest tradeable float as compared to two leading rivals in the same space VVUS and ARNA. All three of these companies are developing a new type of weight loss pill that supposedly has very minor if any side affects and tricks peoples brains into thinking they are ‘full’.
ARNA had some wild up and down trading today and managed to close slightly positive and VVUS had a huge gap up over a week ago on positive late-stage clinical data for its weight-loss drug Qnexa. We are seeing big moves in this sector probably because they are talking about potential billion dollar markets for these drugs. Let’s face it, weight loss is a huge market and a huge problem in this country. If these companies can come up with an effective solution that speeds up people’s weight loss SAFELY then it would seem these companies stand to make some pretty good money.
OREX insiders have recently bought quite a big chunk of shares in the 8 dollar range in August and have quite a big stake in the success or failure of the company.